Zinc-binding of endostatin is essential for its antiangiogenic activity

被引:112
作者
Boehm, T
O'Reilly, MS
Keough, K
Shiloach, J
Shapiro, R
Folkman, J
机构
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Cellular Biol, Boston, MA 02115 USA
[4] NIDDKD, Biotechnol Unit, Bethesda, MD 20892 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Ctr Biochem & Biophys Sci & Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1006/bbrc.1998.9617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endostatin is a potent angiogenesis inhibitor in vitro and in vivo. We used the yeast Pichia pastoris to express and purify soluble endostatin. It was discovered that metal chelating agents can induce N-terminal degradation of endostatin. We theorized that a metal was removed from endostatin which changed the conformation and allowed a contaminating protease to degrade the N-terminus. Atomic absorption and amino acid analysis of endostatin purified from Pichia pastoris and mammalian cells showed a 1:1 molar ratio of Zn2+ to protein. Ding et at have shown that histidines 1, 3, 11, and aspartic acid 76 coordinate the Zn2+ atom (1). An H1/3A double, an H11A, and a D76A single mutant of endostatin were not able to regress Lewis lung carcinoma. We conclude that the ability of endostatin to bind Zn2+ is essential for its antiangiogenic activity. (C) 1998 Academic Press.
引用
收藏
页码:190 / 194
页数:5
相关论文
共 13 条
  • [1] The galvanization of biology: A growing appreciation for the roles of zinc
    Berg, JM
    Shi, YG
    [J]. SCIENCE, 1996, 271 (5252) : 1081 - 1085
  • [2] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    Boehm, T
    Folkman, J
    Browder, T
    OReilly, MS
    [J]. NATURE, 1997, 390 (6658) : 404 - 407
  • [3] ZINC PROTEINS - ENZYMES, STORAGE PROTEINS, TRANSCRIPTION FACTORS, AND REPLICATION PROTEINS
    COLEMAN, JE
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 : 897 - 946
  • [4] DIMERIZATION OF HUMAN GROWTH-HORMONE BY ZINC
    CUNNINGHAM, BC
    MULKERRIN, MG
    WELLS, JA
    [J]. SCIENCE, 1991, 253 (5019) : 545 - 548
  • [5] ZINC MEDIATION OF THE BINDING OF HUMAN GROWTH-HORMONE TO THE HUMAN PROLACTIN RECEPTOR
    CUNNINGHAM, BC
    BASS, S
    FUH, G
    WELLS, JA
    [J]. SCIENCE, 1990, 250 (4988) : 1709 - 1712
  • [6] Zinc-dependent dimers observed in crystals of human endostatin
    Ding, YH
    Javaherian, K
    Lo, KM
    Chopra, R
    Boehm, T
    Lanciotti, J
    Harris, BA
    Li, Y
    Shapiro, R
    Hohenester, E
    Timpl, R
    Folkman, J
    Wiley, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) : 10443 - 10448
  • [7] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [8] Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution
    Hohenester, E
    Sasaki, T
    Olsen, BR
    Timpl, R
    [J]. EMBO JOURNAL, 1998, 17 (06) : 1656 - 1664
  • [9] Angiostatin induces and sustains dormancy of human primary tumors in mice
    OReilly, MS
    Holmgren, L
    Chen, C
    Folkman, J
    [J]. NATURE MEDICINE, 1996, 2 (06) : 689 - 692
  • [10] ANGIOSTATIN - A NOVEL ANGIOGENESIS INHIBITOR THAT MEDIATES THE SUPPRESSION OF METASTASES BY A LEWIS LUNG-CARCINOMA
    OREILLY, MS
    HOLMGREN, L
    SHING, Y
    CHEN, C
    ROSENTHAL, RA
    MOSES, M
    LANE, WS
    CAO, YH
    SAGE, EH
    FOLKMAN, J
    [J]. CELL, 1994, 79 (02) : 315 - 328